Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
December 1, 2022 12:30 AM 2 min read

Elon Musk Says 'Upgraded' Neuralink Brain Chips To Be Placed In Humans In 6 Months: Updates From Show & Tell Event

by Shivdeep Dhaliwal Benzinga Editor
Follow

ArticleFeaturedTickersList12345!!!

Elon Musk-led Neuralink’s “Show & Tell” event took on Wednesday evening after a delay of a month.

What Happened: The event was originally slated for Halloween (Oct. 31). On Wednesday, Musk, who also leads Twitter, SpaceX, and Tesla, tweeted ahead of the commencement to prepare the ground for the upcoming “Show & Tell.”

Musk presented the “Show & Tell” showcase himself on Wednesday, saying the goal of the company was to create a “whole brain interface.”

The entrepreneur said he was confident that the company would be able to address many injury-related problems.

Pointing to the inconspicuousness of Neuralink’s device, Musk joked that he could have a device implanted and no one would know about it.

In less than six months, Neuralink will have its first device in a human, according to Musk. 

See Also: How To Invest In Tech Startups

Musk said the company was not “cavalier” in putting devices into animals and testing is done beforehand. He said Neuralink’s testing is “confirmatory and not exploratory.”

Pager, the Pong-playing macaque has been “upgraded,” said Musk, and the troop of monkeys has expanded to six.

Another Monkey, Sake, was shown typing telepathically on a computer. Musk pointed out that the animal couldn’t actually spell, adding that animal welfare was taken care of.

He said the Neuralink device could be upgraded and reversed, calling them a “fundamental requirement.” 

The first application for Neuralink in humans is to restore vision, Musk said, adding that he was confident it would work on someone who did not have the gift of sight from the beginning.

The other application was in the motor cortex. Musk said individuals inflicted with nervous system diseases, much like the late British theoretical astrophysicist Stephen Hawking, would be able to operate a phone faster than before.

Musk said Neuralink could restore “full body functionality” to someone who has a severed spinal cord.

Why It Matters: Neuralink is Musk’s brain-chip company. Last year, the firm showcased a macaque playing a video game using its thoughts.

The startup has faced allegations of animal cruelty, to which it has responded that Neuralink is not “unique in this regard.”

However, Neuralink has been pipped by an Australian startup that placed the first brain-computer device into a U.S. patient in July. Neuralink has yet to receive a regulatory go-ahead for performing the same procedure.

In July, Neuralink raised $205 million from Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) search unit Google in a Series C-funding round led by Vy Capital.

Read Next: Mark Zuckerberg Calls Out Elon Musk's Neuralink: 'You Want The Mature Version Of That'

 

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
NewsTop StoriesTechElon MuskNeuralink
GOOG Logo
GOOGAlphabet Inc
$323.09-2.49%
Overview
GOOGL Logo
GOOGLAlphabet Inc
$322.67-2.59%
GOOG Logo
GOOGAlphabet Inc
$323.09-2.49%
Overview
GOOGL Logo
GOOGLAlphabet Inc
$322.67-2.59%
Comments
Loading...